Australian Pharmaceutical Industries Ltd
ASX:API

Watchlist Manager
Australian Pharmaceutical Industries Ltd Logo
Australian Pharmaceutical Industries Ltd
ASX:API
Watchlist
Price: 1.53 AUD Market Closed
Market Cap: 753.8m AUD

Intrinsic Value

API price has not been updated for more than 9 months. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the intrinsic value of API.

The Intrinsic Value is calculated as the average of DCF and Relative values:

API Intrinsic Value
Not Available
Base Case Scenario

Fundamental Analysis

Australian Pharmaceutical Industries Ltd
ASX:API
AU
Health Care
Market Cap
753.8m AUD
IPO
Jun 16, 1997
AU
Health Care
Market Cap
753.8m AUD
IPO
Jun 16, 1997
Price
AU$false
EPS
AU$false
Australian Pharmaceutical Industries Ltd
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Heightened competition from discount pharmacy networks and online channels erodes Priceline Pharmacy’s market share and pressures API’s retail margins, potentially reducing profitability in its core segment.

Bull Theses

Strong brand recognition of Priceline Pharmacy and continued expansion of API’s retail footprint position the company for robust consumer demand, supporting increased sales and cross-selling opportunities in skincare, beauty, and over-the-counter products.

Show More Less
How do you feel about API?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Australian Pharmaceutical Industries Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Australian Pharmaceutical Industries Ltd

Current Assets 989.8m
Cash & Short-Term Investments 38.8m
Receivables 589.1m
Other Current Assets 361.9m
Non-Current Assets 540.2m
Long-Term Investments 2.4m
PP&E 230.8m
Intangibles 126.5m
Other Non-Current Assets 180.5m
Efficiency

Free Cash Flow Analysis
Australian Pharmaceutical Industries Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Australian Pharmaceutical Industries Ltd

Revenue
4B AUD
Cost of Revenue
-3.5B AUD
Gross Profit
496.6m AUD
Operating Expenses
-472.7m AUD
Operating Income
23.9m AUD
Other Expenses
-22.5m AUD
Net Income
1.4m AUD
Fundamental Scores

API Profitability Score
Profitability Due Diligence

Australian Pharmaceutical Industries Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

42/100
Profitability
Score

Australian Pharmaceutical Industries Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

API Solvency Score
Solvency Due Diligence

Australian Pharmaceutical Industries Ltd's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Low D/E
High Altman Z-Score
Long-Term Solvency
Short-Term Solvency
40/100
Solvency
Score

Australian Pharmaceutical Industries Ltd's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

API Price Targets Summary
Australian Pharmaceutical Industries Ltd

There are no price targets for API.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for API is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y